Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
This report contains market size and forecasts of Therapeutic Radiopharmaceuticals in global, including the following market information:
Global Therapeutic Radiopharmaceuticals Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Therapeutic Radiopharmaceuticals Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Therapeutic Radiopharmaceuticals companies in 2021 (%)
The global Therapeutic Radiopharmaceuticals market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Radium-223 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Therapeutic Radiopharmaceuticals include Bayer, Novartis, China Isotope & Radiation, Dongcheng, Q BioMed, Curium Pharmaceuticals, Jubilant DraxImage, Lantheus and Spectrum Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Therapeutic Radiopharmaceuticals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Therapeutic Radiopharmaceuticals Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Therapeutic Radiopharmaceuticals Market Segment Percentages, by Type, 2021 (%)
- Radium-223
- Lutetium-177
- Iodine-131
- Other
Global Therapeutic Radiopharmaceuticals Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Therapeutic Radiopharmaceuticals Market Segment Percentages, by Application, 2021 (%)
- Thyroid
- Bone Metastasis
- Lymphoma
- Other
Global Therapeutic Radiopharmaceuticals Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Therapeutic Radiopharmaceuticals Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Therapeutic Radiopharmaceuticals revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Therapeutic Radiopharmaceuticals revenues share in global market, 2021 (%)
- Key companies Therapeutic Radiopharmaceuticals sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Therapeutic Radiopharmaceuticals sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bayer
- Novartis
- China Isotope & Radiation
- Dongcheng
- Q BioMed
- Curium Pharmaceuticals
- Jubilant DraxImage
- Lantheus
- Spectrum Pharmaceuticals
- Progenics Pharmaceuticals
- International Isotopes
